Enzyme News and Research

RSS

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

A recent study has demonstrated the antiviral effectiveness of cetylpyridinium chloride against SARS-CoV-2 infection.

22 Aug 2022

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Researchers explored how the natural alterations inside the SARS-CoV-2 glycan barrier affect the spike protein dynamics.

22 Aug 2022

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

A recent study examines the potential effects of tobacco use on COVID-19.

21 Aug 2022

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Researchers assessed the SARS-CoV-2 variants of concern (VOCs) transmission dynamics and neutralization by vaccine-induced antibodies and monoclonal antibodies (mAbs).

19 Aug 2022

Host anti-viral factors and pathways regulating SARS-CoV-2 infection

In a new study, researchers identified host anti-viral factors and pathways regulating SARS-CoV-2 infection.

18 Aug 2022

Waning of humoral immune responses to SARS-CoV-2 after 14 months of infection

Researchers assessed humoral immune responses to and neutralization of the SARS-CoV-2 Delta (B.1.617.2) variant of concern after two months (T1) and 14 months (T2) of asymptomatic or mild wild-type (WT) SARS-CoV-2 infections.

18 Aug 2022

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Researchers investigated the role of the CD98 glycoprotein in inducing an inflammatory response to SARS-CoV-2 in patients of progressive fibrosis interstitial lung diseases, including the archetypal PFILD, idiopathic pulmonary fibrosis.

18 Aug 2022

Eating grapes may reduce the risk of fatty liver disease

In a recent study published in the journal Foods, eating grapes can extend life expectancy by five years and reduce non-alcoholic fatty liver disease risk in mice fed high-fat diets.

17 Aug 2022

Researchers create novel mouse model for mapping protein communication between organs

Our many different organ systems are in constant communication with each other. During exercise, for example, muscles send out signals to fat and liver tissue to release their energy sources.

17 Aug 2022

Research suggests a new model of how beige fat biogenesis is controlled

Once considered an inert tissue, fat – or adipose tissue – is now known to play an active role in the body's critical functions by secreting hormones that regulate hunger and body temperature.

17 Aug 2022

Acid ceramidase is a SARS-CoV-2 host factor, study says

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg in the summer of 2020. However, the mechanism of this inhibition was utterly unclear, so the teams continued their research.

17 Aug 2022

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Researchers demonstrated the relevance of the P681H spike mutation in the SARS-CoV-2 Alpha variant.

17 Aug 2022

Discovery explains how impaired metabolism triggers neuroendocrine tumors in the adrenal glands

Researchers have deciphered a signaling cascade through which inborn errors in metabolism provoke deadly neuroendocrine tumors in the adrenal glands.

16 Aug 2022

UT Southwestern's cryo-EM images shed light on the mechanisms behind Wnt signaling activation

Using UT Southwestern's Cryo-Electron Microscopy Facility, researchers have captured images of an enzyme for Wnt lipidation, which is pivotal to human development and cancer and crucial for Wnt signaling activation.

16 Aug 2022

Impact of SARS-CoV-2 Omicron subvariant breakthrough infections on memory responses

Researchers examined antibodies (Abs) generated by memory B cells (MBCs) after three and four SARS-CoV-2 exposures by infections with SARS-CoV-2 Delta and Omicron BA.1 variants, respectively.

16 Aug 2022

Comparison of seroconversion rates and antibody responses in children across the three SARS-CoV-2 waves in Melbourne, Australia

Researchers evaluated antibody responses to SARS-CoV-2 variants in children.

16 Aug 2022

Enzyme News and Research

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Host anti-viral factors and pathways regulating SARS-CoV-2 infection

Waning of humoral immune responses to SARS-CoV-2 after 14 months of infection

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Eating grapes may reduce the risk of fatty liver disease

Researchers create novel mouse model for mapping protein communication between organs

Research suggests a new model of how beige fat biogenesis is controlled

Acid ceramidase is a SARS-CoV-2 host factor, study says

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Discovery explains how impaired metabolism triggers neuroendocrine tumors in the adrenal glands

UT Southwestern's cryo-EM images shed light on the mechanisms behind Wnt signaling activation

Impact of SARS-CoV-2 Omicron subvariant breakthrough infections on memory responses

Comparison of seroconversion rates and antibody responses in children across the three SARS-CoV-2 waves in Melbourne, Australia

Computational pipeline for the early identification of emerging SARS-CoV-2 variants

Rapid and efficient strategy for the development and design of SARS-CoV-2 neutralizing humanized nanobody constructs

A non-covalent inhibitor of 3C-like protease effectively inhibits SARS-CoV-2 replication

Understanding the DNA Damage Response in Innate Immunity eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo